West Pharmaceutical Services, I vs Solventum Corporation
A head-to-head of West Pharmaceutical Services, I (WST) and Solventum Corporation (SOLV) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | WST | SOLV |
|---|---|---|
| Market Cap | $25.31B | $14.08B |
| P/E (TTM) | 47.79 | 9.96 |
| Forward P/E | 34.01 | 10.42 |
| P/S | 6.48 | 1.54 |
| P/B | 8.67 | 2.85 |
| EV/EBITDA | 24.06 | 15.51 |
| Dividend Yield | 0.24% | — |
| Profit Margin | 16.85% | 17.33% |
| Gross Margin | 35.89% | 53.47% |
| Operating Margin | 20.09% | 7.59% |
| Revenue Growth (YoY) | +21.01% | -3.09% |
| FCF Yield | 2.19% | -1.60% |
| Debt / Equity | 7.50 | 102.21 |
| Current Ratio | 2.71 | 1.07 |
Which is better: West Pharmaceutical Services, I or Solventum Corporation?
- ✓Larger by market cap: West Pharmaceutical Services, I
- ✓Cheaper valuation (lower P/E): Solventum Corporation
- ✓More profitable (net margin): Solventum Corporation
- ✓Faster revenue growth: West Pharmaceutical Services, I
- ✓Higher free-cash-flow yield: West Pharmaceutical Services, I
Across 12 available metrics, Solventum Corporation leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.